JPMorgan Chase & Co. set a €59.60 ($69.30) price target on Gerresheimer (ETR:GXI) in a research note issued to investors on Tuesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other research analysts have also weighed in on GXI. Hauck & Aufhaeuser set a €50.00 ($58.14) target price on shares of Gerresheimer and gave the stock a sell rating in a research report on Tuesday, December 17th. Credit Suisse Group set a €87.00 ($101.16) target price on shares of Gerresheimer and gave the stock a buy rating in a research report on Tuesday, October 15th. Independent Research set a €69.00 ($80.23) target price on shares of Gerresheimer and gave the stock a neutral rating in a research report on Tuesday, November 26th. HSBC set a €85.00 ($98.84) target price on shares of Gerresheimer and gave the stock a buy rating in a research report on Monday, October 14th. Finally, Goldman Sachs Group set a €84.00 ($97.67) target price on shares of Gerresheimer and gave the stock a buy rating in a research report on Monday, February 10th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. The company has an average rating of Hold and an average target price of €73.07 ($84.96).

Shares of GXI opened at €71.55 ($83.20) on Tuesday. The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 65.99. The firm’s 50-day moving average is €69.13 and its two-hundred day moving average is €68.36. Gerresheimer has a twelve month low of €56.50 ($65.70) and a twelve month high of €74.80 ($86.98). The firm has a market capitalization of $2.25 billion and a P/E ratio of 10.85.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Article: Diluted Earnings Per Share

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.